Thanks Stockrock. Well, there you go. My apologies all. I was...

Thanks Stockrock. Well, there you go. My apologies all.

I was recalling@Relax1 posting some time back about Zhejiang Tiandi's new patent on a treatment flow incorporating MABR: 38240993

When partners have created such models, with MABR as an integral component, it struck me that it would make sense for them to only order modules from us, for them to incorporate into their own patented designs. When I read about these provincial assembly points, my first thought was Zhejiang Tiandi. However, it remains clear to me that iTest or anyone else, linked as they are to large-scale EPC competency, would seek out efficiencies like this too.

In terms of the last paragraph, Adam was quick to mention on the webcast that going to capacity for the 1 incumbent line in Changzhou was not to imply that this would necessarily be the case at all times from now on.